Priscille Brodin
Impact in
- Infectious Diseases top 0.1%
- Tuberculosis Research and Epidemiology
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Tuberculosis Research and Epidemiology 63
- HIV/AIDS drug development and treatment 8
- Virology 9
- HIV Research and Treatment 9
- Co-authors
- Bernard LebleuÉric VivèsStewart T. ColeRoland BroschAlexander S. PymLaleh MajlessiClaude LeclercMichel Huerre
- Journals
- Infection and Immunity (6 papers)PLoS Pathogens (6 papers)Scientific Reports (4 papers)Journal of Medicinal Chemistry (4 papers)PLoS ONE (4 papers)
- Partner nations
- FranceSouth KoreaUnited Kingdom
In The Last Decade
Priscille Brodin
106 papers receiving 9.1k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Infectious Diseases 5.0k
- Molecular Medicine 649
- Epidemiology 3.9k
- Immunology 1.8k
- Microbiology 463
Countries citing papers authored by Priscille Brodin
This map shows the geographic impact of Priscille Brodin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Priscille Brodin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Priscille Brodin more than expected).
Fields of papers citing papers by Priscille Brodin
This network shows the impact of papers produced by Priscille Brodin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Priscille Brodin. The network helps show where Priscille Brodin may publish in the future.
Co-authors
The 25 scholars most cited alongside Priscille Brodin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 11 | |
| 4 | 2023 | 0 | |
| 5 | 2021 | 17 | |
| 6 | 2021 | 19 | |
| 7 | 2019 | 30 | |
| 8 | 2019 | 33 | |
| 9 | 2019 | 37 | |
| 10 | 2018 | 62 | |
| 11 | 2017 | 72 | |
| 12 | 2017 | 37 | |
| 13 | 2017 | 58 | |
| 14 | 2017 | 67 | |
| 15 | 2015 | 146 | |
| 16 | 2011 | 44 | |
| 17 | 2006 | 86 | |
| 18 | 2005 | 109 | |
| 19 | Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti Hit paper breakdown → | 2002 | 558 |
| 20 | 2001 | 2 |
About Priscille Brodin
Priscille Brodin is a scholar working on Infectious Diseases, Virology, Epidemiology, Endocrinology and Immunology, having authored 109 papers that have together received 9.3k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (63 papers), Mycobacterium research and diagnosis (43 papers), Cancer therapeutics and mechanisms (13 papers), Biochemical and Molecular Research (12 papers), Immunodeficiency and Autoimmune Disorders (11 papers), Pneumocystis jirovecii pneumonia detection and treatment (10 papers), HIV Research and Treatment (9 papers) and HIV/AIDS drug development and treatment (8 papers). The work is most often cited by research in Infectious Diseases (5.0k citations), Molecular Medicine (649 citations), Epidemiology (3.9k citations), Immunology (1.8k citations) and Microbiology (463 citations). Priscille Brodin has collaborated with scholars based in France, South Korea and United Kingdom. Frequent co-authors include Bernard Lebleu, Éric Vivès, Stewart T. Cole, Roland Brosch, Alexander S. Pym, Laleh Majlessi, Claude Leclerc, Michel Huerre, Carmen Buchrieser and Caroline Demangel. Their work appears in journals such as Infection and Immunity, PLoS Pathogens, Scientific Reports, Journal of Medicinal Chemistry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.